Gemcitabine Hydrochloride
Showing 1 - 25 of 3,923
Lymphoma, Solid Tumor Trial in Buffalo (Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study)
Terminated
- Lymphoma
- Solid Neoplasm
- Gemcitabine Hydrochloride
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
- Gemcitabine hydrochloride and albumin binding paclitaxel
-
Shanghai, Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Dec 8, 2022
Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Ascorbate
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Cancer Center
Aug 29, 2023
Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston
Active, not recruiting
- Metastatic Urothelial Carcinoma
- +2 more
- Doxorubicin Hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- dovitinib lactate
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Head Neck Cancer Trial in Singapore (carboplatin,, cisplatin, gemcitabine HCl)
Active, not recruiting
- Head and Neck Cancer
- carboplatin,
- +4 more
-
Singapore, SingaporeNational Cancer Centre - Singapore
Sep 27, 2022
Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Bladder Cancer Trial in Larissa (Gemcitabine Hydrochloride combined with continuous saline irrigation, Epirubicin Hydrochloride
Recruiting
- Bladder Cancer
- Gemcitabine Hydrochloride combined with continuous saline irrigation
- Epirubicin Hydrochloride combined with continuous saline irrigation
-
Larissa, Larissa/Thessaly, GreeceUrology Department, University of Thessaly, University Hospital
Jan 25, 2022
Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,
Recruiting
- Metastatic Kidney Medullary Carcinoma
- +4 more
- Doxorubicin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Cleveland (Regorafenib, Gemcitabine Hydrochloride)
Terminated
- Metastatic Pancreatic Adenocarcinoma
- Regorafenib
- Gemcitabine Hydrochloride
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 1, 2022
Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,
Active, not recruiting
- Non-Squamous Non-Small Cell Lung Carcinoma
- +7 more
- Nivolumab
- +3 more
-
Abington, Pennsylvania
- +1 more
Sep 14, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Dasatinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 15, 2021
Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)
Not yet recruiting
- Pancreas Cancer
- Gemcitabine
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Aug 15, 2022
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in United States
Active, not recruiting
- Pancreatic Adenocarcinoma
- +3 more
- Gemcitabine Hydrochloride
- +5 more
-
Duarte, California
- +3 more
Mar 17, 2022
Nasopharyngeal Carcinoma Trial in China (TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride
Recruiting
- Nasopharyngeal Carcinoma
- TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride Injection
- +2 more
-
Guangzhou, Guangdong, China
- +3 more
Nov 28, 2022
Lymphoma Trial in Duarte, South Pasadena (biological, drug, other)
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
-
Duarte, California
- +1 more
Feb 28, 2022
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Completed
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +5 more
- gemcitabine hydrochloride
- bendamustine hydrochloride
-
Atlanta, Georgia
- +1 more
Oct 21, 2021
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Phoenix, Jacksonville, Rochester (Gemcitabine
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Gemcitabine Hydrochloride
- +3 more
-
Phoenix, Arizona
- +2 more
Oct 6, 2021
Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)
Completed
- Bladder Cancer
- induction cisplatin
- +13 more
-
Atlanta, Georgia
- +10 more
May 23, 2022
Intrahepatic Cholangiocarcinoma Trial in Shanghai (Toripalimab, Lenvatinib mesylate capsules, Placebo IV)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Toripalimab
- +6 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital affiliated to Fudan University
Aug 12, 2022